AI assistant
Sending…
InspireMD, Inc. — Director's Dealing 2016
Jul 27, 2016
34187_dirs_2016-07-27_5ae3213c-6e37-4db5-bf47-13d58a343a3b.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: InspireMD, Inc. (NSPR)
CIK: 0001433607
Period of Report: 2016-07-25
Reporting Person: Shore Craig (CFO and CAO)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2016-07-25 | Common Stock | A | 440619 | — | Acquired | 455981 | Direct |
Derivative Transactions
| Date | Security | Exercise Price | Code | Shares | A/D | Expiration | Underlying | Ownership |
|---|---|---|---|---|---|---|---|---|
| 2016-07-25 | Options (right to buy) | $0.19 | A | 440619 | Acquired | 2026-07-25 | Common Stock (440619) | Direct |
Footnotes
F1: Represents a restricted stock award that is subject to forfeiture until vested. This award vests in three equal annual installments, with 1/3 vesting on each of July 25, 2017, July 25, 2018 and July 25, 2019, subject to Mr. Shore's continued service.
F2: The options vest in three equal annual installments, with 1/3 becoming exercisable on each of July 25, 2017, July 25, 2018 and July 25, 2019, subject to Mr. Shore's continued service.
More from InspireMD, Inc.
Declaration of Voting Results & Voting Rights Announcements
2026
Jun 3
Board/Management Information
2026
May 22
Interim / Quarterly Report
2026
May 7
Annual Report
2026
Apr 20
Capital/Financing Update
2026
Apr 3
Capital/Financing Update
2026
Apr 3
Annual Report
2026
Mar 18
Major Shareholding Notification
2026
Feb 17
Major Shareholding Notification
2026
Feb 11
Major Shareholding Notification
2026
Feb 2